Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]
Karin P.S. Langenberg(Princess Máxima Center), Patrick Kemmeren(Heidelberg University), Eugène T.P. Verwiel(Radboud University Nijmegen), Miriam Stumpf(Princess Máxima Center), Richard Volckmann(Amsterdam University Medical Centers), Marc H W Wijnen(Princess Máxima Center), Laura S. Hiemcke‐Jiwa(Princess Máxima Center), Uri Ilan(Princess Máxima Center), Judith M. Boer(Princess Máxima Center), Marjolijn C.J. Jongmans(Utrecht University), Miranda P. Dierselhuis(Princess Máxima Center), Arjan Boltjes(Utrecht University), Josef Vormoor(University Medical Center Utrecht), Frank C. P. Holstege(University Medical Center Utrecht), Jayne Y. Hehir‐Kwa, Gnana Prakash Balasubramanian(German Cancer Research Center), Rob Pieters(Princess Máxima Center), Monique L. den Boer(Princess Máxima Center), Mariëtte E.G. Kranendonk(Princess Máxima Center), Stefan M. Pfister(Heidelberg University), Edwin Sonneveld(Princess Máxima Center), Linda Schild(Amsterdam UMC Location University of Amsterdam), Simone Punt(Utrecht University), Marijn A. Scheijde‐Vermeulen(Heidelberg University), Michael T. Meister(German Cancer Research Center), Eelco W. Hoving(Princess Máxima Center), Pieter Wesseling(Radboud University Nijmegen), Sander R. van Hooff(Princess Máxima Center), Jette J. Bakhuizen(Heidelberg University), Ronald R. de Krijger(University Medical Center Utrecht), Natasha K. A. van Eijkelenburg(Princess Máxima Center), Kimberley Ober(Erasmus MC Cancer Institute), Esmé Waanders(University Medical Center Utrecht), C. Michel Zwaan(Princess Máxima Center), Marco M.J. Koudijs(Heidelberg University), Cornelis M. van Tilburg(German Cancer Research Center), Esther Hulleman(Amsterdam UMC Location VUmc), Roland P. Kuiper(Princess Máxima Center), Marcel Kool(German Cancer Research Center), Mirjam Blattner-Johnson(Cornell University), Lennart Kester(Royal Netherlands Academy of Arts and Sciences), Jasper van der Lugt(Princess Máxima Center), Eleonora J. Looze(Princess Máxima Center), David Jones(German Cancer Research Center), Barbara C. Jones(German Cancer Research Center), Max M. van Noesel(Radboud University Nijmegen), Freerk van Dijk, Uta Flucke(Princess Máxima Center), Olaf Witt(German Cancer Research Center), Willemijn B. Breunis(Amsterdam UMC Location University of Amsterdam)
Cited by 1
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k